Effectiveness of a standardised cleaning protocol to prevent malignant cell contamination during EBUS-TBNA: Results from a European multicentre study
BACKGROUND: Endobronchial ultrasound (EBUS) and transoesophageal ultrasound with a bronchoscope (EUS-B) are key techniques for mediastinal staging in lung cancer. The 9th TNM classification underscores the prognostic importance of accurate station-specific nodal assessment. However, the optimal sampling strategy remains uncertain, particularly regarding needle reuse between N2 stations due to the risk of cross-contamination. METHODS: We conducted a prospective multicentre study including patients undergoing EBUS and/or EUS-B for diagnosis or staging of lung cancer or metastatic disease. A standardised transbronchial needle aspiration (TBNA) cleaning protocol was evaluated. The primary endpoint was the absence of malignant cells in post-cleaning needle rinse samples. RESULTS: Of 164 enrolled patients, 162 were included in the final analysis, comprising 270 sampled targets, with malignancy confirmed in 76.3%. The mean cleaning time was 148.8 ± 40.9 seconds per target, and the needle was visually assessed as clean in 89.3% of cases. Among malignant cases, post-cleaning needle rinse samples were negative for malignant cells in 92.2% and positive or suspicious in 7.8%. No clinical or procedural variables were associated with cleaning failure. Visual assessment of needle cleanliness did not correlate with cytological findings. No complications were observed. CONCLUSION: A standardised needle-cleaning protocol is safe and effective in reducing malignant cell contamination during EBUS and EUS-B. However, residual contamination persists in a minority of cases, indicating that needle reuse may carry a small risk of cross-contamination between targets. This approach may represent a pragmatic alternative to routine needle exchange in clinical practice.
Authors
- Telma Chantal Almeida Sequeira (ORCID: https://orcid.org/0000-0001-8031-7136)
- Marija Petrinec-Primozic
- Aleš Rozman (ORCID: https://orcid.org/0000-0002-5607-9032)
- Artur Bartczak
- António Bugalho (ORCID: https://orcid.org/0000-0003-3951-1134)
- Maciej Gnass
- Ralf Eberhardt (ORCID: https://orcid.org/0000-0001-6119-5428)
- Paula Borralho (ORCID: https://orcid.org/0000-0002-8556-2090)
- Bernd Feyerabend
- Martin Mechsner
- Artur Szlubowski (ORCID: https://orcid.org/0000-0002-2806-2559)
Institutions
- University of Lisbon (PT)
- University of Ljubljana (SI)
- Instituto Português de Oncologia Francisco Gentil (PT)
- IPO Porto (PT)
- University Clinic of Pulmonary and Allergic Diseases Golnik (SI)
- Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer (DE)
- Mammazentrum Hamburg (DE)
- Krakow Cardiovascular Research Institute (PL)
- Dermatologikum Hamburg (DE)
- Asklepios (DE)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- Pulmonology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1080/25310429.2026.2765868
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00